Aspen Aerogels Q2 2025 Earnings Preview: Revenue Down 38.4% Y/Y, EPS Estimate at -$0.12.

Aspen Aerogels is set to announce Q2 2025 earnings on Thursday, August 7th. The consensus EPS estimate is -$0.12 and the revenue estimate is $72.53M (-38.4% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward, while revenue estimates have seen 0 upward revisions and 7 downward.

Aspen Aerogels (NYSE: ASPN) is scheduled to release its Q2 2025 earnings before the market opens on Thursday, August 7th. Analysts expect the company to report earnings of -$0.12 per share and revenue of $72.53 million for the quarter [1]. Over the last three months, earnings per share (EPS) estimates have seen three downward revisions, while revenue estimates have seen seven downward revisions, indicating a cautious outlook from analysts.

Aspen Aerogels operates in the energy infrastructure and sustainable insulation materials markets. The company's stock has been volatile, with a market capitalization of $647.03 million and a price-to-earnings ratio of -2.26. The stock's one-year low is $4.16, and the one-year high is $33.15. The company's debt-to-equity ratio is 0.40, with a quick ratio of 3.53 and a current ratio of 4.22. Aspen Aerogels' CEO, Donald R. Young, recently bought 20,000 shares of the company's stock at an average price of $5.35 per share, increasing his position by 3.77% [1].

Several institutional investors have shown interest in Aspen Aerogels. Acadian Asset Management LLC, Caxton Associates LLP, Goldman Sachs Group Inc., Integrated Wealth Concepts LLC, and AQR Capital Management LLC have all bought shares in the first quarter of 2025. Goldman Sachs Group Inc. raised its position by 89.7% in the first quarter, owning 1,274,356 shares worth $8,143,000 after acquiring an additional 602,586 shares [1].

Analysts have issued various ratings for Aspen Aerogels. Barclays reiterated an "equal weight" rating with a target price of $7.00, while Oppenheimer cut the stock from an "outperform" rating to a "market perform" rating. The average rating is "Moderate Buy" with a consensus price target of $18.44 [1].

Aspen Aerogels' Q2 2025 earnings will provide insights into the company's financial performance and help investors make informed decisions. The company's ability to navigate the volatile energy and insulation markets will be a key focus for investors.

References:
[1] https://www.marketbeat.com/instant-alerts/aspen-aerogels-aspn-to-release-quarterly-earnings-on-thursday-2025-07-31/
[2] https://seekingalpha.com/news/4480181-aspen-aerogels-q2-2025-earnings-preview